Evidence map›Paper›PMID 31170827›Full record

ArticleAIDS care2020

Implementing an integrated community based health systems strengthening approach to improve HIV survival in Northern Togo.

Kevin P Fiori, Hayley M Belli, Molly E Lauria, Lisa R Hirschhorn, Jennifer Schechter, Emily Hansman, Nandita Rajshekhar, Venance Katin, Sesso Gbeleou, Meskerem Grunitsky-Bekele and 1 more

Open access · greenAbstract read
In one paragraph

Article in AIDS care, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Kevin P FioriDepartment of Pediatrics, Albert Einstein College of Medicine, Bronx, NY, USA.ORCID 0000-0003-1370-7366
Hayley M BelliNew York University School of Medicine, New York, NY, USA.
Molly E LauriaCommunity Health Systems Lab, Integrate Health/Santé Intégrée, Kara, Togo and New York, NY, USA.
Lisa R HirschhornCommunity Health Systems Lab, Integrate Health/Santé Intégrée, Kara, Togo and New York, NY, USA.
Jennifer SchechterIntegrate Health/Santé Intégrée, Kara, Togo and New York, NY, USA.
Emily HansmanIntegrate Health/Santé Intégrée, Kara, Togo and New York, NY, USA.
Nandita RajshekharIntegrate Health/Santé Intégrée, Kara, Togo and New York, NY, USA.
Venance KatinIntegrate Health/Santé Intégrée, Kara, Togo and New York, NY, USA.
Sesso GbeleouIntegrate Health/Santé Intégrée, Kara, Togo and New York, NY, USA.
Meskerem Grunitsky-BekeleIntegrate Health/Santé Intégrée, Kara, Togo and New York, NY, USA.
Vincent Palokinam PitcheProgramme National de Lutte Contre le VIH/SIDA-IST, Lomé, Togo.
Albert Einstein College of Medicine · USNew York University · USNorthwestern University · US

Funding

The Center of Excellence in Promoting LHS Operations and Research at Einstein/Montefiore (EXPLORE)K12HS026396 · AHRQ · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI MARANTZ, PAUL R, RINKE, MICHAEL L · 2018 to 2022
$3.3M
AHRQ HHS K12 HS026396
6 · The paper itself

Abstract

To disseminate lessons learned from the implementation experience of a public-private sector partnership, we describe a comprehensive HIV/AIDS program including 5-year survival outcomes for individuals who initiated antiretroviral therapy (ART) treatment in Togo from 2010 to 2015. A retrospective case study analysis was conducted from a cohort of patients receiving ART at an HIV/AIDS care clinic in Kara Region, Togo. Kaplan-Meier curves with Log rank tests were used to compare estimated survival curves by demographic and clinical characteristics. Associations were described between survival probability and age, gender, World Health Organization (WHO) disease stage, and timing of ART initiation. Cox proportional hazard model was used to determine predictors of mortality. After approximately five-years since ART initiation (1780 days), there were 114 deaths, with a survival probability of 75.3% (95% CI: 70.3-80.6%). Participants with advanced WHO disease stage were more likely at risk of death relative to patients categorized as WHO Stage 1, with Stage 4 approximately 9 times more likely (aHR 9.22, 95% CI 4.29-19.84). Our study suggests that delivering comprehensive HIV care through a private-public partnership may serve as a model to expand and improve HIV/AIDS care as well as high quality primary care.

Indexed as

HIV InfectionsAdultAnti-HIV AgentsFemaleHumansMaleProportional Hazards ModelsRetrospective StudiesTogoAnti-HIV Agentscommunity health workersHealth systems strengtheningHIV/AIDSTogo

Identifiers

PMID31170827
PMCPMC7357197
OpenAlexW2948195867

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.